Introduction
Public reporting of hospital performance has become a common strategy for monitoring and improving the quality of healthcare. Such reports are intended to stimulate quality improvement among providers by identifying areas where quality is lacking and by providing motivation for protection of reputation or market share (Berwick, James, & Coye, 2003; Hibbard, 2008a) . In addition, public reporting may be used by consumers to select higher quality providers. Although there is some debate about whether or not consumers use hospital performance data to choose their site of care (Faber, Bosch, Wollersheim, Leatherman, & Grol, 2009; Romano & Zhou, 2004) , guiding consumers' choices continues to be a widely stated rationale for public reporting (CMS, 2008; Hibbard, 2008b) .
The Centers for Medicare and Medicaid Services (CMS) was mandated by the Deficit Reduction Act of 2005 to maintain a consumer-targeted website publicly reporting hospital performance on quality of care, which CMS has stated will "empower consumer choice" (CMS, 2008) . The current version of the web-site presents hospital-specific mortality rates for acute myocardial infarction (AMI) and heart failure (HF) and data about several process measures for each condition. Thus, in order to use the information presented to choose a hospital, a consumer must create some composite assessment of overall hospital performance, although the consumer generally is not explicitly aware of doing this (Hibbard, 2008b) .
However, research has shown that consumers' decision-making capacity is reduced as the number of variables for which data are presented increases (Hibbard, Slovic, & Jewett, 1997; Vaiana & McGlynn, 2002) . Simplifying the comparative quality data for easy and meaningful interpretation by consumers has been suggested as a future goal of hospital performance reporting. CMS and (CMS, 2004 ) the Agency for Healthcare Research and Quality (AHRQ; Hibbard, 2008a) have advocated the strategy of reducing consumers' cognitive burden by explicitly calculating composite scores from the available information and presenting those, rather than leaving consumers to create their own implicit composites.
Furthermore, consumers are generally more concerned about actual results of care (e.g., mortality) than technical processes of care (Lansky, 1998) . Therefore, if the purpose is to guide consumer choices, the data presented should predict outcomes at individual hospitals during the time period in which the consumer is making a choice. However, CMS data necessarily are historical (i.e., from a period before the time when the consumer might be choosing a hospital), and it is not clear how predictive historical data are of current hospital performance. To our knowledge, no study has examined how well hospital performance data from the previous year on AMI and HF-whether as individual data elements or in composite form-predict mortality rates in the current year. Other work has focused on historical mortality (with or without incorporating volume) predicting "current" surgical or NICU mortality (Birkmeyer, Dimick, & Staiger, 2006; Dimick, Staiger, Baser, & Birkmeyer, 2009; Luft & Romano, 1993; Rogowski et al., 2004) .
Our aim in this study was to identify the approach to summarizing the information available at the time a consumer would be making a choice that best predicts current year hospital mortality rates and would thus be most useful in achieving CMS' stated goal of guiding consumer choices. We performed this study for AMI and HF admissions because those are the only conditions for which process and mortality data were available on a national sample of hospitals for a 2-year period (pneumonia data were available for only 1 year). Although we realize consumers usually cannot choose their hospital during AMI or an acute exacerbation of HF, they are often able to select a hospital for chronic management of their cardiac disease and that selection may affect the hospital to which they are admitted for the acute event. In addition, the lessons from studying AMI and HF may be applicable to other conditions in which choice is more frequently feasible.
Methods

Study Design and Sample
We performed an observational cohort study of all acute care hospitals reporting performance on process and outcome measures for AMI and HF to CMS from July 2005 to June 2007. The chosen time period provided the most current publicly available data for hospital performance on these measures. For this study, July 2005 to June 2006 is defined as "Year 0" or the prior year, and July 2006 to June 2007 is defined as "Year 1" or the current year. We excluded hospitals with less than 25 eligible patients for measurement in either year as CMS deems performance rates for these hospitals to be unstable (CMS, 2009 
Quality Measures
We included process measures that were reported for at least 80% of hospitals in order to calculate a composite score for as many hospitals as possible. Process measures for AMI included aspirin at arrival and at discharge; beta blocker at arrival and at discharge; smoking cessation counseling; and angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) for left ventricular systolic dysfunction. Excluded process measures for AMI were thrombolytic agent received within 30 min, and primary percutaneous coronary intervention received within 120 min (this has been reduced to 90 min for more recent years) of arrival (only available from 63% and 54% of hospitals, respectively). All HF process measures were included as follows: assessment of patients' left ventricular function, ACE inhibitor or ARB for left ventricular dysfunction, and smoking cessation counseling.
Hospital 30-day risk-adjusted mortality rates for AMI and HF were abstracted from CMS' website (CMS, 2009). The risk-adjustment models have been validated against other models of risk adjustment and found to have high correlation over time (Krumholz et al., 2006) .
Calculating Composite Measures
There are many ways to construct a composite measure. For example, composite scores may be "compensatory" (a poor score on one individual measure can be compensated by a good score on another measure) or "conjunctive" (all measures must be met to achieve a good score). In addition, individual measures forming a composite score may be transformed and/or weighted differently.
We used the composite construction method recommended by CMS (CMS, 2004; Shwartz et al., 2008 )-a compensatory composite calculated using denominator-based weights-to create two disease-specific composite measures for both AMI and HF: process performance only and overall performance (process plus mortality). The denominator-based approach divides the number of times the processes were followed in a hospital (e.g., for AMI care) by the total number of times patients were eligible for each AMI measure. This approach also is currently used by The Joint Commission to facilitate consumer interpretation (Commission, 2008) .
To construct an overall composite score, we transformed mortality rates into survival rates (1-mortality rate) so that the outcome measure had the same directionality as the process measures (i.e., closer to 100% represented better performance). We then applied equal weighting based upon the number of process and outcome measures used to obtain the composite score, as recommended by CMS. For example, our AMI overall composite score was constructed of six process measures and one outcome measure, so a weight of six of seven was applied to the process measure composite and one of seven to mortality rate. Then the two scores were added to give an overall composite performance score. The performance of the composite scores using Year 0 data to predict Year 1 mortality rates for each hospital was compared to using Year 0 mortality rates alone.
Sensitivity Analyses
Although CMS recommends the composite weighting approach described above, we recognized that a consumers' own weighting preferences may vary. As a sensitivity analysis, therefore, we tested alternative combinations of weighting for the components comprising a composite score. We tested different weights by incrementally increasing the weight on the survival rate and decreasing the weight on processes to determine whether this affected the ability of the overall composite to predict Year 1 mortality rates.
We also analyzed whether the exclusion of the two process measures for AMI that were missing for many hospitals-thrombolytic agent received within 30 min, and primary percutaneous coronary intervention received within 120 min of arrival-altered our findings. We recreated our process and overall composite scores using the subset of hospitals that reported on one or both of these process measures, adjusting the composite weighting to account for the inclusion of additional quality measures.
Because there was minimal variation among hospitals for some of the included process measures, we hypothesized that identifying hospitals with very low composite scores might have more predictive power than using the scores as continuous variables, since hospitals with very low composite scores would have the most extreme deviations in process performance from average. Therefore, we also tested whether a model capturing performance as a binary variable indicating whether a hospital was in the lowest or highest decile of hospital composite scores better predicted Year 1 risk-adjusted hospital mortality rates than the models using composite scores as continuous variables. We also treated each of the 10 deciles of hospital performance as dummy variables to further test the predictive value of both extremes of the performance distribution.
Statistical Analysis
We calculated the mean performance rate with standard deviation for individual process measures, the process composite score, and the overall (processes and mortality) composite score, along with 30-day risk-adjusted hospital mortality rate for AMI and HF in Year 0. Because we wanted to know how useful the information on different measures was for informing patients of their mortality risk, we used linear regression to determine the strength of the relationship between disease-specific hospital 30-day risk-adjusted mortality rate in Year 1 and Year 0 disease-specific process composite score, overall composite score, and mortality rate alone. In these models, Year 1 mortality rate was the dependent variable, and Year 0 data were used to calculate the independent variables. Regression models reveal the relationship between two or more variables by estimating the line that best fits the observed data. A measure of the fit is provided by the coefficient of determination (r-squared), which reveals how well the variation in the independent variable explains the variation in the dependent variable. An r-square value of 0 implies that none of the variation in the dependent variable is explained by the independent variable, and an r-square value of 1 that means 100% of the variation in the dependent variable is explained by the independent variable.
To demonstrate the potential clinical impact of consumers using different components of the available performance data to choose a hospital, we calculated the number of potentially avoidable deaths at 30 days for AMI and HF if consumers were to choose hospitals in the top decile instead of the bottom decile, based on each approach to summarizing the available data-individual process scores, process composite score, overall composite score, and 30-day risk-adjusted mortality rate (Replogle & Johnson, 2007) . The difference in arithmetic means was used (i.e., assigning equal weights to each hospital) because the hospital-specific rates were already adjusted for hospital level differences in patient characteristics, volume, etc. In this case, because we were comparing the means between two categories of hospitals (those in the top decile and those in the bottom decile, we used the analysis of variance (ANOVA) to determine statistical significance. ANOVA is a general technique that uses the F-statistics to test the hypothesis that the means among two or more populations are equal.
The University of California, San Francisco institutional review board determined that this study was exempt from review. Analyses were conducted using Stata/SE version 10 (StataCorp, College Station, TX). All reported p values are two-sided and considered significant at .05.
Results
Sample and Measures
The sample for our analyses included 190,637 (Year 0) and 178,586 (Year 1) patients with AMI and 326,627 (Year 0) and 303,338 (Year 1) patients with HF from 1,868 hospitals. Hospital characteristics in Year 0 are shown in Table 1 .
Rates of hospital performance for individual processes, the process composite, and the overall composite measures as well as 30-day risk-adjusted mortality rate for AMI and HF are shown in Table 2 . Mean hospital 30-day risk-adjusted mortality rate was 16.3 (SD 1.6) and 11.0 (SD 1.4) per 100 patients presenting with AMI and HF, respectively.
Relationship Between Year 0 Hospital Performance and Year 1 30-day Risk-Adjusted Mortality Rate
The hospital process composite and overall composite from Year 0 accounted for a small but statistically significant portion of the variation in 30-day risk-adjusted hospital mortality in the following year for AMI (3.6% and 3.9%, both p < .001), but not for HF (3.4% and 3.2%; both p > .05; Figure 1 ). In contrast, the explanatory power of 30-day risk-adjusted mortality in the current year was several-fold greater than both the process measure alone and the composite measures. Percentages of variation in the following year's 30-day risk-adjusted mortality explained by current year mortality was 8.6 (p < .001) for AMI and 17.9% for HF, respectively (p < .001; Figure 1 ).
We calculated the number of potentially avoidable deaths at 30 days in Year 1 associated with a patient choosing a hospital in the top versus bottom decile of Year 0 composite or mortality performance data to give a clinically relevant assessment of the relative advantage to using each type of measure for decision making (Table 3 ). For AMI, using Year 0 30-day risk-adjusted mortality rate alone produced a larger reduction in potentially avoidable deaths than using process composite or overall composite scores though all were significant (1.31 lives per 100 patients vs. 0.61 and 0.56 lives per 100 patients, respectively, p < .001). Consumer selection of a hospital in Year 1 based upon Year 0 hospital AMI 30-day riskadjusted mortality rate alone would find a reduction in potentially avoidable deaths of 1.31 lives per 100 patients (p < .001). For HF, use of Year 0 hospital process (−0.03 lives per 100 patients, p = .68) or overall (−0.08 lives per 100 patients, p = .63) composite measures to select hospitals did not yield any significant benefit in the risk of 30-day risk-adjusted mortality in Year 1. However, using the Year 0 30-day mortality rate for HF yielded a significant reduction in Year 1 potentially avoidable deaths of 2.12 lives per 100 patients (p < .001).
Sensitivity Analyses
We varied the weights in the overall composite measures to reflect the fact that consumers might assign a wide range of weights to processes relative to mortality. However, no process composite weighting between 0.01 and 1.00, explained as much variation in Year 1 mortality as using the Year 0 mortality rate alone (equivalent to a process weight of zero).
We also recalculated the process and overall performance composite scores for AMI with the inclusion of the two measures for AMI that were excluded in our initial analysis (thrombolytic agent received within 30 min and primary percutaneous coronary intervention received within 120 min of arrival) for 618 hospitals that reported both measures. The weighted composites for those hospitals did not explain a significant percentage of the variation (5.2%, p = .35 and 5.5%, p = .22, respectively) in Year 1 mortality.
Finally, to test the hypothesis that extremes of performance might be most predictive when there was little overall variation in process measure performance, we explored the impact of using a model replacing the process and overall composites with a binary variable indicating whether a hospital was in the lowest or highest decile of hospital performance on these composites in Year 0 to predict Year 1 mortality. These models had no additional predictive power compared to models using the Year 0 mortality alone. For AMI, the model using the binary variable indicating bottom or top decile hospital performance on the process and overall composite explained only 3.2% (p = .03) and 3.1% (p = .03) of the variation in Year 1 mortality rates, respectively. For HF, the model using the binary variable indicating bottom or top hospital performance on the process and overall composite did not explain a significant portion of the variation in Year 1 mortality rates (1.1%, p = .58 and 1.0%, p = . 91, respectively). A sensitivity analysis evaluating the predictive ability of the extremes in the hospital performance on the process and overall composites, which used dummy variables for each decile of performance, did not improve the predictive value of the data compared to hospital performance analyzed as a continuous variable.
Discussion
There is a growing body of evidence that consumers often find hospital quality reports difficult to interpret (Faber et al., 2009 ). In response, many organizations, including CMS, have advocated using composite scores to reduce the amount of data presented. This is the first study to assess whether a composite score created from Hospital Compare data would give consumers better information about their expected outcomes than the individual performance measures. We found that 30-day mortality alone had better, though still small, predictive ability for subsequent hospital mortality rates than tested composite measures for AMI and HF.
It is not a surprising finding that Year 0 process measures explain little of the variation in Year 1 mortality, given prior research that even same year process measure performance explains a relatively small portion of mortality (i.e., process performance in Year 0 does not explain much of mortality variation in Year 0; Bradley et al., 2006; Werner & Bradlow, 2006) . Other approaches to creating composite ratings of hospitals that include variables other than mortality have also shown little ability to predict future mortality performance (Chen, Radford, Wang, Marciniak, & Krumholz, 1999; Krumholz, Rathore, Chen, Wang, & Radford, 2002; Wang et al., 2007) . Furthermore, we found that consumer use of Year 0 30-day mortality rates alone to choose better performing hospitals would have yielded potentially better outcomes (in the form of greater number of deaths avoided) than using composite scores. Taken together, the prior research and our study suggest that to create a consumer-focused hospital performance report that is simpler and more meaningful (for CMS' stated purpose of guiding consumer choice [CMS, 2008] ), including only historical outcomes such as 30-day risk-adjusted mortality rates in the report may be more effective than creating a composite of mortality and process data.
Our findings should not be interpreted to suggest that it is not worthwhile to collect process measure data. Many of the currently used process measures have been shown to affect mortality in randomized controlled trials, and the weak association with mortality in an observational study does not negate those findings. Rather, process measure data can and should be used for other important purposes, such as reporting to hospitals their own performance relative to benchmarks, with the expectation of hospitals using the data in internal quality improvement programs (Jencks, Huff, & Cuerdon, 2003) . Additionally, if new process measures are developed and tested in clinical trials that show better prediction of outcomes, the usefulness of including these process measures in reports to consumers should be reevaluated.
We realize some may be uncomfortable with the idea of publicly reporting only riskadjusted 30-day mortality rates. This discomfort may reflect continuing uncertainty about whether differences in risk-adjusted mortality rates truly reflect differences in hospital performance or are related to other variables, such as unmeasured patient clinical or socioeconomic status variables, access to care, or hospital characteristics. Additionally, the risk-adjustment model developed by CMS adjusts for the existence of comorbidities, but not their severity (Krumholz et al., 2006) . Although researchers (and CMS) should continue to seek better methods of risk adjustment, we feel that it is unlikely that improved riskadjustment methodologies would change our findings (in fact, it might increase the relative predictive power of Year 0 mortality, because it would be a truer measure of the hospital's performance in Year 0). Notwithstanding, we acknowledge that unmeasured confounders have the potential to affect results of any analysis.
Furthermore, the reality is that public reporting (including of risk-adjusted mortality) is already occurring at the national level and in many states as well, with the stated goal of directing patients to hospitals with better outcomes (CMS, 2008) . Thus, the question of what subset of available performance measures will best predict future mortality rates remains relevant, as it is a major priority for many policymakers and can have an impact on all providers.
There are other limitations to this study. Our dataset consists of publicly available measurements of hospital quality and does not allow for the examination of other outcomes potentially affected by process performance and of interest to consumers, such as hospital inpatient and 1-year risk-adjusted mortality (Saposnik et al., 2008) . However, these outcomes are not currently reported on Hospital Compare and thus are not likely currently used by consumers in their assessments of hospital quality. Thirty-day risk-adjusted readmission rates are just now being released by CMS and were not available for incorporation in this study. In addition, CMS has changed its reporting of outcomes data from 12-to 36-month aggregate hospital rates, adding another challenge for investigators and consumers alike as they try to understand their utility. The addition of a time lag in reporting of mortality data by CMS will not likely improve its use as a predictor of "current" mortality rates (Luft & Romano, 1993) . Further research is needed to assess whether the introduction of a time lag in the reporting of outcomes data will diminish our findings. Another important caveat to our potentially avoidable deaths calculation is that it must be significantly discounted for feasibility issues, such as the fact that patients might not live near a top decile hospital. Further research that incorporates these feasibility considerations is needed for more precise estimates on the overall potential impact on mortality.
Lastly, as the length of time a set of process measures has been included in CMS initiatives increases, more hospitals reach a ceiling of process measure performance (Fonarow & Peterson, 2009; Normand, Wolf, & McNeil, 2008) . As the variation in process measure performance declines, it becomes less likely that incorporating this information will improve our ability to predict hospital outcomes. This may contribute to the minimal predictive benefit of hospital process measure performance in our study. However, even using an indicator for falling into the bottom decile of hospital performance did not produce models that predict Year 1 mortality nearly as well as models using Year 0 mortality alone.
Despite the plethora of available public performance reports, public reporting of quality measures has not had a great impact on consumer behavior (Fung, Lim, Mattke, Damberg, & Shekelle, 2008) . Our study demonstrates that a composite score created as CMS, AHRQ, and others recommend to improve comprehension of data has little predictive value to the consumer trying to identify a hospital that will improve his or her chances of surviving an AMI or an episode of HF. Mortality rate from the prior year alone is a stronger predictor of 30-day risk-adjusted mortality rate in the consumer's current year. Thus, public reports focused on 30-day risk-adjusted mortality rate would likely reduce the cognitive burden on consumers and may more directly address policymakers' goals of facilitating consumer identification of hospitals with better outcomes. a Process composite score reflects hospital performance on all included disease-specific individual process measures. Possible range 0-1.
b Overall composite score reflects hospital performance on all included disease-specific individual process and survival rates. Possible range 0-1.
c Mortality rate is expressed per 100 patients presenting with the disease.
